Clinical Trials on Tumor, Solid

Total 17761 results

Athenex, Inc.
Merck Sharp & Dohme LLC

Terminated

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

Solid Tumor

United States
Istituto Clinico Humanitas

Completed

Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

SOLID TUMOR

Italy
Fujifilm Pharmaceuticals U.S.A., Inc.

Completed

A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

Solid Tumor

United States
Athenex, Inc.
PharmaEssentia; Zenith Technology Corporation Limited

Completed

A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel

Solid Tumor

New Zealand, Taiwan, Australia
Eli Lilly and Company

Terminated

A Study of LY3405105 in Participants With Advanced Cancer

Solid Tumor

United States, France, Spain, Taiwan, Canada
7 Hills Pharma, LLC
Frontage Clinical Services, Inc.

Completed

A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects

Solid Tumor

United States
Impact Therapeutics, Inc.

Completed

IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers

Solid Tumor

China
Celgene

No longer available

Expanded Access for Marizomib

Solid Tumor

United States
Amsterdam UMC, location VUmc
Cristal Therapeutics

Completed

PET Study With [89Zr]-Df-CriPec® Docetaxel

Solid Tumor

Netherlands
Hanmi Pharmaceutical Company Limited

Completed

Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers

Solid Tumor

Korea, Republic of
Impact Therapeutics, Inc.

Completed

IMP4297 Food Effect Trial in Healthy Volunteers

Solid Tumor

China
Samsung Medical Center

Withdrawn

Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy (TSC1/2_SC)

Solid Tumor

Korea, Republic of
Onconova Therapeutics, Inc.

Completed

Safety, Pharmacokinetics and Clinical Activity of Oral Rigosertib in Solid Tumors

Solid Tumor

United States
Merck KGaA, Darmstadt, Germany
Threshold Pharmaceuticals

Completed

A Phase 1 TH-302 Mass Balance Trial

Solid Tumor

Germany
Hadassah Medical Organization

Unknown

A Study: Pure CBD as Single-agent for Solid Tumor.

Solid Tumor
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer

Solid Tumor
Samyang Biopharmaceuticals Corporation

Completed

Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer

Solid Tumor

Korea, Republic of
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets

Advanced Solid Tumor or Hematologic Tumor

China
University of Alberta

Withdrawn

Imaging of Advanced Tumours Using [131]I-IAZA

Locally Advanced Solid Tumors | Metastatic Solid Tumors

Canada
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Locally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid Tumors

Australia, United States, Canada
Enloe Health
Robert A. Winn Diversity in Clinical Trials Award Program

Not yet recruiting

A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention (GENESIS)

Solid Tumor, Adult
Fudan University

Recruiting

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Solid Tumor

China
Pyramid Biosciences

Not yet recruiting

A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors

Solid Tumor

United States
New York Stem Cell Foundation Research Institute
Stevens Institute of Technology

Recruiting

Personalized Models for Cancer Research

Solid Tumor, Adult

United States
Jemincare

Not yet recruiting

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Solid Tumor, Adult
Qingdao Sino-Cell Biomedicine Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; West China... and other collaborators

Recruiting

HS-IT101 Injection in the Treatment of Advanced Solid Tumors

Solid Tumor

China
Institut Curie
Merck Sharp & Dohme LLC; ProLynx LLC

Not yet recruiting

A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors (POP-ART)

Solid Tumor

France
Aummune Ltd.

Recruiting

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Solid Tumor

Israel
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

Solid Tumor

China
Nuwacell Biotechnologies Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Not yet recruiting

A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor

Solid Tumor

China
Ascendo Biotechnology Co., Ltd.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141

Metastatic Solid Tumor
Fujian Haixi Pharmaceuticals Co., Ltd.

Recruiting

Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors

Solid Tumor

China
Shanghai Haiyan Pharmaceutical Technology Co.,...

Recruiting

A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

Solid Tumor

China
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Australia
Ever Supreme Bio Technology Co., Ltd.

Not yet recruiting

A Safety And Efficacy Study Of Allogeneic CAR Gamma-Delta T Cells in Subjects With Relapsed/Refractory Solid Tumors (CAR001)

Solid Tumor

Taiwan
Zhejiang Doer Biologics Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor

China
Shanghai Jiatan Pharmatech Co., Ltd

Recruiting

A Study of WX390 in Patients With Advanced Solid Tumors

Solid Tumor

China
ImmunoGenesis

Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

Solid Tumor

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Australia
Suzhou BlueHorse Therapeutics Co., Ltd.

Not yet recruiting

A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors

Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University...
RenJi Hospital

Not yet recruiting

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients With Advanced Solid Tumors

Solid Tumor

China
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Recruiting

Autologous Tumour Vaccine Trial

Solid Tumor

Australia
TiumBio Co., Ltd.
Merck Sharp & Dohme LLC

Recruiting

Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Solid Tumor

United States
Peking University
UTC Therapeutics Inc.

Not yet recruiting

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Solid Tumor
L & L biopharma Co., Ltd., Shanghai China

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） (MEETCD8-001)

Solid Tumor

China
St. Jude Children's Research Hospital

Recruiting

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Solid Tumor

United States
Shen Lin

Not yet recruiting

A Study of RD14-01 in Patients With Advanced Solid Tumors

Solid Tumor
Abbisko Therapeutics Co, Ltd

Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors

Solid Tumor

United States, China
Sanofi

Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Solid Tumor

United States, Israel, Netherlands, Spain

3

Subscribe